Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,802 papers from all fields of science
Search
Sign In
Create Free Account
NXL 104
Known as:
NXL-104
, NXL104
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
avibactam
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Inactivation of TEM-1 by avibactam (NXL-104): insights from quantum mechanics/molecular mechanics metadynamics simulations.
Jacopo Sgrignani
,
G. Grazioso
,
M. De Amici
,
G. Colombo
Biochemistry
2014
Corpus ID: 23376466
The fast and constant development of drug-resistant bacteria represents a serious medical emergence. To overcome this problem…
Expand
2012
2012
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole.
L. Dubreuil
,
S. Mahieux
,
C. Neut
,
C. Miossec
,
J. Pace
International Journal of Antimicrobial Agents
2012
Corpus ID: 6724611
2012
2012
Activity of Ceftaroline-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Collected from USA Hospitals in 2011
H. Sader
,
R. Flamm
,
M. Castanheira
,
R. Jones
2012
Corpus ID: 86306556
• Among 337 Enterobacter spp. strains, 97.3% were inhibited by ceftarolineavibactam at ≤0.5 mg/L. Meropenem (MIC 90, ≤0.06 mg/L…
Expand
2011
2011
NXL104, un nouvel inhibiteur de β-lactamases à large spectre
V. Cattoir
2011
Corpus ID: 73014829
2011
2011
X-ray Crystal Structure of the Acinetobacter baumannii OXA-24/40 Class D Carbapenemase Inhibited by NXL104
J. Docquier
,
M. Benvenuti
,
+4 authors
M. T. Black
2011
Corpus ID: 103327185
2011
2011
β-Lactamase Inhibitor NXL104 Helps Overcome Resistance of Pathogens
D. Holzman
2011
Corpus ID: 74788483
When used with ceftazidime or other β-lactam antibiotics, NXL104, a potent inhibitor of β-lactamase enzymes, becomes a powerful…
Expand
2011
2011
Antimicrobial Activity of Ceftazidime Avibactam (formerly NXL104) Tested Against Gram-Negative Organisms Causing Infections in Medical Centers from Europe, Latin America and the Asia-Pacific Region
H. Sader
,
D. Farrell
,
R. Flamm
,
J. Bell
,
J. Turnidge
,
R. Jones
2011
Corpus ID: 74529078
E. coli (934) 58.0 88.7 97.2 99.9 100.0 – – – ESBL-phenotype (245) 29.0 69.4 91.0 99.6 100.0 – – – Klebsiella spp. (1003) 36.3 70…
Expand
2010
2010
Potent Activity of Ceftazidime/NXL104 Tested Against Enterobacteriaceae Isolates Carrying Multiple β-lactamase Enzymes
M. Castanheira
,
P. Rhomberg
,
R. Jones
,
D. Farrell
2010
Corpus ID: 85944630
The presence of multiple β-lactamases in a single cephalosporin-resistant isolate has been recognized as an alarming fact since…
Expand
2009
2009
Bactericidal Activity of Ceftaroline Combined with NXL104 Against Critical Targeted Organisms Possessing Various Resistance Mechanisms
M. Castanheira
,
I. Critchley
,
Gregory C. Williams
2009
Corpus ID: 85712073
Background: Ceftaroline (CPT), a broad-spectrum cephalosporin with gram-positive activity (including anti-MRSA), was tested in…
Expand
2008
2008
Importance of NXL104 Pharmacokinetics (PK) in the Pharmacodynamics (PD) of Ceftazidime+NXL104 Combinations in an In Vitro Hollow Fiber Infection Model
M. Borgonovi
2008
Corpus ID: 101791470
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE